タンザニア - 英語 - Tanzania Medicinces & Medical Devices Authority

cadila healthcare limited, india - febuxoastat - film coated tablet - 80

タンザニア - 英語 - Tanzania Medicinces & Medical Devices Authority

cadila pharmaceuticals limited, india - febuxoastat - film coated tablet - 80

タンザニア - 英語 - Tanzania Medicinces & Medical Devices Authority

cadila pharmaceuticals limited, india - febuxostat - tablet, coated - 40

タンザニア - 英語 - Tanzania Medicinces & Medical Devices Authority

cadila healthcare limited, india - febuxostat - tablet, coated - 40

カナダ - 英語 - Health Canada

adienne sa - thiotepa - powder for solution - 15mg - thiotepa 15mg - antineoplastic agents

カナダ - 英語 - Health Canada

adienne sa - thiotepa - powder for solution - 100mg - thiotepa 100mg - antineoplastic agents

イスラエル - 英語 - Ministry of Health

mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 100 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

イスラエル - 英語 - Ministry of Health

mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

イスラエル - 英語 - Ministry of Health

mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

イスラエル - 英語 - Ministry of Health

mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.